Annual ROE
-76.09%
-37.72%-98.31%
December 31, 2023
Summary
- As of February 7, 2025, CLPT annual return on equity is -76.09%, with the most recent change of -37.72% (-98.31%) on December 31, 2023.
- During the last 3 years, CLPT annual ROE has risen by +118.71% (+60.94%).
- CLPT annual ROE is now -101.69% below its all-time high of 4511.17%, reached on December 31, 2014.
Performance
CLPT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-64.36%
+0.14%+0.22%
September 30, 2024
Summary
- As of February 7, 2025, CLPT quarterly return on equity is -64.36%, with the most recent change of +0.14% (+0.22%) on September 30, 2024.
- Over the past year, CLPT quarterly ROE has increased by +3.58% (+5.27%).
- CLPT quarterly ROE is now -113.30% below its all-time high of 483.82%, reached on March 31, 2017.
Performance
CLPT Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CLPT ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -98.3% | +5.3% |
| 3 y3 years | +60.9% | -50.6% |
| 5 y5 years | +54.7% | +56.3% |
CLPT ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -98.3% | at low | -87.5% | +17.2% |
| 5 y | 5-year | -98.3% | +60.9% | -87.5% | +78.7% |
| alltime | all time | -101.7% | +73.1% | -113.3% | +96.5% |
ClearPoint Neuro ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -64.36%(-0.2%) |
| Jun 2024 | - | -64.50%(-12.5%) |
| Mar 2024 | - | -73.75%(-5.1%) |
| Dec 2023 | -76.09%(+98.3%) | -77.70%(+14.4%) |
| Sep 2023 | - | -67.94%(+17.1%) |
| Jun 2023 | - | -58.01%(+27.0%) |
| Mar 2023 | - | -45.69%(+19.0%) |
| Dec 2022 | -38.37%(-31.9%) | -38.38%(+4.9%) |
| Sep 2022 | - | -36.59%(+2.4%) |
| Jun 2022 | - | -35.72%(+4.0%) |
| Mar 2022 | - | -34.33%(-10.8%) |
| Dec 2021 | -56.33%(-71.1%) | -38.48%(-9.9%) |
| Sep 2021 | - | -42.73%(-12.4%) |
| Jun 2021 | - | -48.78%(-32.0%) |
| Mar 2021 | - | -71.78%(-76.3%) |
| Dec 2020 | -194.80%(+7.2%) | -302.45%(+31.2%) |
| Sep 2020 | - | -230.61%(+53.6%) |
| Jun 2020 | - | -150.11%(-2.5%) |
| Mar 2020 | - | -153.94%(+8.1%) |
| Dec 2019 | -181.73%(+8.2%) | -142.38%(-3.3%) |
| Sep 2019 | - | -147.22%(-18.9%) |
| Jun 2019 | - | -181.63%(-19.3%) |
| Mar 2019 | - | -225.14%(+32.5%) |
| Dec 2018 | -167.95% | -169.88%(+15.6%) |
| Sep 2018 | - | -146.95%(+25.3%) |
| Jun 2018 | - | -117.29%(-20.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | -147.89%(-22.9%) |
| Dec 2017 | -282.59%(-126.5%) | -191.89%(-23.9%) |
| Sep 2017 | - | -252.08%(-86.1%) |
| Jun 2017 | - | -1815.57%(-475.3%) |
| Mar 2017 | - | 483.82%(+16.3%) |
| Dec 2016 | 1067.31%(+150.3%) | 415.97%(+23.1%) |
| Sep 2016 | - | 337.78%(+146.5%) |
| Jun 2016 | - | 137.03%(-9.5%) |
| Mar 2016 | - | 151.41%(-22.4%) |
| Dec 2015 | 426.49%(-90.5%) | 195.19%(-17.8%) |
| Sep 2015 | - | 237.55%(-17.1%) |
| Jun 2015 | - | 286.62%(+4.4%) |
| Mar 2015 | - | 274.65%(+137.9%) |
| Dec 2014 | 4511.17%(+4250.6%) | 115.47%(+49.5%) |
| Sep 2014 | - | 77.22%(+0.1%) |
| Jun 2014 | - | 77.11%(-2.3%) |
| Mar 2014 | - | 78.95%(-52.4%) |
| Dec 2013 | 103.69%(+38.8%) | 165.79%(+70.3%) |
| Sep 2013 | - | 97.36%(+11.9%) |
| Jun 2013 | - | 87.00%(+76.6%) |
| Mar 2013 | - | 49.25%(-31.9%) |
| Dec 2012 | 74.73%(+96.4%) | 72.34%(+6.4%) |
| Sep 2012 | - | 67.98%(+37.3%) |
| Jun 2012 | - | 49.52%(+13.4%) |
| Mar 2012 | - | 43.65%(+57.3%) |
| Dec 2011 | 38.05% | 27.75% |
FAQ
- What is ClearPoint Neuro annual return on equity?
- What is the all time high annual ROE for ClearPoint Neuro?
- What is ClearPoint Neuro annual ROE year-on-year change?
- What is ClearPoint Neuro quarterly return on equity?
- What is the all time high quarterly ROE for ClearPoint Neuro?
- What is ClearPoint Neuro quarterly ROE year-on-year change?
What is ClearPoint Neuro annual return on equity?
The current annual ROE of CLPT is -76.09%
What is the all time high annual ROE for ClearPoint Neuro?
ClearPoint Neuro all-time high annual return on equity is 4511.17%
What is ClearPoint Neuro annual ROE year-on-year change?
Over the past year, CLPT annual return on equity has changed by -37.72% (-98.31%)
What is ClearPoint Neuro quarterly return on equity?
The current quarterly ROE of CLPT is -64.36%
What is the all time high quarterly ROE for ClearPoint Neuro?
ClearPoint Neuro all-time high quarterly return on equity is 483.82%
What is ClearPoint Neuro quarterly ROE year-on-year change?
Over the past year, CLPT quarterly return on equity has changed by +3.58% (+5.27%)